$ENSC
Ensysce Biosciences, Inc.

2021 Q1 Form 10-Q Financial Statement

#000149315221013768 Filed on June 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $250.6K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $490.5K
YoY Change
% of Gross Profit
Research & Development $324.4K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $814.9K $915.2K
YoY Change -10.96% 381.67%
Operating Profit
YoY Change
Interest Expense $598.5K
YoY Change -49.28%
% of Operating Profit
Other Income/Expense, Net $2.184M
YoY Change
Pretax Income -$951.7K $1.867M
YoY Change -150.97% 88.62%
Income Tax $74.63K
% Of Pretax Income 4.0%
Net Earnings -$947.7K $1.793M
YoY Change -152.87% 129.84%
Net Earnings / Revenue -378.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$59.24K $281.2K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.03K $168.0K
YoY Change -89.26% -88.8%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $190.4K $42.38K
YoY Change 349.27% -57.62%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $228.2K $274.3K
YoY Change -16.79% -82.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.69M
YoY Change
Other Assets $61.28K $61.33M
YoY Change -99.9% -69.92%
Total Long-Term Assets $12.75M $61.33M
YoY Change -79.21% -69.94%
TOTAL ASSETS
Total Short-Term Assets $228.2K $274.3K
Total Long-Term Assets $12.75M $61.33M
Total Assets $12.98M $61.60M
YoY Change -78.93% -70.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $319.2K $3.494M
YoY Change -90.87% 1064.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $319.2K $3.494M
YoY Change -90.87% 773.56%
LONG-TERM LIABILITIES
Long-Term Debt $460.0K $1.566M
YoY Change -70.63%
Other Long-Term Liabilities $10.31M $47.00M
YoY Change -78.07% 571.43%
Total Long-Term Liabilities $10.77M $48.57M
YoY Change -77.83% 593.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $319.2K $3.494M
Total Long-Term Liabilities $10.77M $48.57M
Total Liabilities $11.09M $52.06M
YoY Change -78.7% 603.52%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.894M $9.541M
YoY Change
Total Liabilities & Shareholders Equity $12.98M $61.60M
YoY Change -78.93% -70.04%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$947.7K $1.793M
YoY Change -152.87% 129.84%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$266.2K -$234.4K
YoY Change 13.56% -19.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$62.50K $134.6M
YoY Change -100.05% 89649.79%
Cash From Investing Activities $134.6M
YoY Change 89649.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 297.5K -135.3M
YoY Change -100.22% 1352734.9%
NET CHANGE
Cash From Operating Activities -266.2K -234.4K
Cash From Investing Activities 134.6M
Cash From Financing Activities 297.5K -135.3M
Net Change In Cash $0.00 -893.2K
YoY Change -100.0% 495.47%
FREE CASH FLOW
Cash From Operating Activities -$266.2K -$234.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 LACQ Deferred Cost Current
DeferredCostCurrent
USD
CY2021Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
USD
CY2021Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
shares
CY2021Q1 LACQ Earnings Per Share Basic And Diluted Subject To Possible Redemption
EarningsPerShareBasicAndDilutedSubjectToPossibleRedemption
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
USD
CY2021Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
USD
CY2021Q1 LACQ Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
USD
CY2021Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
USD
CY2021Q1 us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
USD
CY2020Q1 LACQ Amounts Returned To Trust Account For Excess Redemptions Previously Withdrawn
AmountsReturnedToTrustAccountForExcessRedemptionsPreviouslyWithdrawn
USD
CY2020Q1 LACQ Change In Value Of Common Stock Subject To Redemption
ChangeInValueOfCommonStockSubjectToRedemption
USD
CY2020Q1 LACQ Waiver Of Portion Of Deferred Underwriting Fee
WaiverOfPortionOfDeferredUnderwritingFee
USD
CY2021Q1 LACQ Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
USD
CY2021Q1 LACQ Due To Stockholders For Redemption Of Common Stock
DueToStockholdersForRedemptionOfCommonStock
USD
CY2021Q1 LACQ Interest Earned On Marketable Securities Held In Trust Account Subject To Possible Redemption
InterestEarnedOnMarketableSecuritiesHeldInTrustAccountSubjectToPossibleRedemption
USD
CY2020Q1 LACQ Interest Earned On Marketable Securities Held In Trust Account Subject To Possible Redemption
InterestEarnedOnMarketableSecuritiesHeldInTrustAccountSubjectToPossibleRedemption
USD
CY2021Q1 LACQ Interest Withdrawn For Payment Of Taxes Subject To Possible Redemption
InterestWithdrawnForPaymentOfTaxesSubjectToPossibleRedemption
USD
CY2020Q1 LACQ Interest Withdrawn For Payment Of Taxes Subject To Possible Redemption
InterestWithdrawnForPaymentOfTaxesSubjectToPossibleRedemption
USD
CY2021Q1 LACQ Net Income Loss Subject To Possible Redemption
NetIncomeLossSubjectToPossibleRedemption
USD
CY2020Q1 LACQ Net Income Loss Subject To Possible Redemption
NetIncomeLossSubjectToPossibleRedemption
USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
shares
CY2021Q1 LACQ Earnings Per Share Basic And Diluted Subject To Possible Redemption
EarningsPerShareBasicAndDilutedSubjectToPossibleRedemption
CY2021Q1 LACQ Net Income Loss Subject To Possible Redemption
NetIncomeLossSubjectToPossibleRedemption
USD
CY2020Q1 LACQ Net Income Loss Subject To Possible Redemption
NetIncomeLossSubjectToPossibleRedemption
USD

Files In Submission

Name View Source Status
0001493152-21-013768-index-headers.html Edgar Link pending
0001493152-21-013768-index.html Edgar Link pending
0001493152-21-013768.txt Edgar Link pending
0001493152-21-013768-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
lacq-20210331.xsd Edgar Link pending
lacq-20210331_cal.xml Edgar Link unprocessable
lacq-20210331_def.xml Edgar Link unprocessable
lacq-20210331_lab.xml Edgar Link unprocessable
lacq-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending